ALEVA NEUROTHERAPEUTICS SA  |  EPFL INNOVATION PARK - BUILDING D  |  1015 LAUSANNE  |  SWITZERLAND  |  INFO@ALEVA-NEURO.COM

OUR INVESTORS

Financing Events:

Series D financing round of 13 MUSD was completed in Sept 2017 and led by Forrestal Capital

Series C financing round of 10 MUSD was completed in May 2016 and led by Integer Inc. (NYSE: INT)

Series B financing round of 8 MUSD was completed in September 2014.

Series A financing round of 14 MUSD was completed in April 2012.

Main investors are: